Phase I trial of concurrent chemo radiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).

被引:0
|
作者
Katori, H [1 ]
Tsukuda, M [1 ]
Ishitoya, J [1 ]
Mikami, Y [1 ]
Matsuda, H [1 ]
Tanigaki, Y [1 ]
Horiuchi, C [1 ]
Ikeda, Y [1 ]
Ono, M [1 ]
Hirose, S [1 ]
机构
[1] Yokohama City Univ, Yokohama, Kanagawa 232, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5560
引用
收藏
页码:503S / 503S
页数:1
相关论文
共 50 条
  • [31] Docetaxel and cisplatin concurrent with radiotherapy versus 5-fluorouracil and cisplatin concurrent with radiotherapy in treatment for locally advanced oesophageal squamous cell carcinoma: a randomized clinical study
    Zhao, Tao
    Chen, Hao
    Zhang, Tingrong
    MEDICAL ONCOLOGY, 2012, 29 (05) : 3017 - 3023
  • [32] Randomized phase II trial of cisplatin and radiotherapy with or without erlotinib in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Martins, Renato
    Parvathaneni, Upendra
    Sharma, Anand K.
    Raez, Luis E.
    Papagikos, Michael A.
    Yunus, Furhan
    Bauman, Julie E.
    Eaton, Keith D.
    Liao, Jay Justin
    Mendez, Eduardo
    Futran, Neal
    Kurland, Brenda F.
    Wang, David X.
    Xiaoyu, Shawn
    Wallace, Sarah G.
    Hayes, David N.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [33] Late chemo-intensification with cisplatin and 5-fluorouracil as an adjunct to radiotherapy: A pragmatic approach for locally advanced head and neck squamous cell carcinoma
    Chufal, Kundan S.
    Rastogi, Madhup
    Srivastava, Madhu
    Pant, M. C.
    Bhatt, M. L. B.
    ORAL ONCOLOGY, 2006, 42 (05) : 517 - 525
  • [34] Phase II trial of docetaxel, cisplatin, 5-fluorouracil (TPF) in locally advanced and metastatic squamous cell carcinoma (SCC) of the penis (CRUK/09/001).
    Bahl, Amit
    Nicholson, Steve
    Harland, Stephen John
    Chester, John D.
    Pickering, Lisa M.
    Barber, Jim
    Cruickshank, Clare
    Burnett, Stephanie M.
    Waters, Rachel
    Hall, Emma
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [35] Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinoma
    Takatsugu Mizumachi
    Akihiro Homma
    Tomohiko Kakizaki
    Tomohiro Sakashita
    Satoshi Kano
    Hiromitsu Hatakeyama
    Kazuhiko Tsuchiya
    Koichi Yasuda
    Rikiya Onimaru
    Hiroki Shirato
    Jun Taguchi
    Yasushi Shimizu
    Ichiro Kinoshita
    Hirotoshi Akita
    Satoshi Fukuda
    International Journal of Clinical Oncology, 2015, 20 : 431 - 437
  • [36] Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinoma
    Mizumachi, Takatsugu
    Homma, Akihiro
    Kakizaki, Tomohiko
    Sakashita, Tomohiro
    Kano, Satoshi
    Hatakeyama, Hiromitsu
    Tsuchiya, Kazuhiko
    Yasuda, Koichi
    Onimaru, Rikiya
    Shirato, Hiroki
    Taguchi, Jun
    Shimizu, Yasushi
    Kinoshita, Ichiro
    Akita, Hirotoshi
    Fukuda, Satoshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (03) : 431 - 437
  • [37] Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck:: A randomised phase II study
    Fonseca, E
    Grau, JJ
    Sastre, J
    García-Gómez, JM
    Rueda, A
    Pastor, M
    Lara, MA
    Navalón, M
    Berrocal, A
    Tisaire, JL
    Cruz, JJ
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (09) : 1254 - 1260
  • [38] Concurrent Chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Patients with Nasopharyngeal Carcinoma
    Komatsu, Masanori
    Arai, Yasuhiro
    Yabuki, Kenichiro
    Sano, Daisuke
    Shiono, Osamu
    Sakuma, Yasunori
    Nishimura, Goushi
    Takahashi, Masahiro
    Taguchi, Takahide
    Oridate, Nobuhiko
    ANTICANCER RESEARCH, 2015, 35 (12) : 6861 - 6867
  • [39] Phase I/II study of erlotinib combined with cisplatin and radiotherapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Herchenhorn, D
    Dias, FL
    Araújo, CM
    Ferreira, CG
    Bezerra, M
    Hermont, P
    Lima, RA
    Porto, AL
    Pereira, CG
    Martins, RG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 523S - 523S
  • [40] Phase I/II study of erlotinib combined with cisplatin and radiotherapy for locally advanced squamous cell carcinoma of the head and neck (SCCHN).
    Herchenhorn, D.
    Dias, F. L.
    Ferreira, C. G.
    Bezerra, M.
    Fonseca, A. J.
    Mora, P.
    Pineda, R. M.
    Fontao, K.
    Knust, R. E.
    Martins, R. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 298S - 298S